Use of TGF beta superfamily antagonists to make dopaminergic neurons from embryonic stem cells
First Claim
1. A method for producing a neural cell population from human embryonic stem (hES) cells, comprising:
- a) obtaining a population of hES cells;
b) optionally initiating differentiation of the hES cells into a heterogeneous population of precursor cells; and
then c) culturing the cells in a medium containing one or more added TGF-β
Superfamily Antagonists so as to produce a population having one or more of the following features;
i) at least 50% of the cells express polysialylated NCAM ii) at least 50% of the cells express β
-tubulin III;
or iii) at least 10% of the cells express both microtubule-associated protein 2 (MAP-2) and tyrosine hydroxylase.
1 Assignment
0 Petitions
Accused Products
Abstract
This invention provides a system for efficiently producing differentiated cells from pluripotent cells, such as human embryonic stem cells. Rather than permitting the cells to form embryoid bodies according to established techniques, differentiation is effected directly in monolayer culture on a suitable solid surface. The cells are either plated directly onto a differentiation-promoting surface, or grown initially on the solid surface in the absence of feeder cells and then exchanged into a medium that assists in the differentiation process. The solid surface and the culture medium can be chosen to direct differentiation down a particular pathway, generating a cell population that is remarkably uniform. The methodology is well adapted to bulk production of committed precursor and terminally differentiated cells for use in drug screening or regenerative medicine.
33 Citations
14 Claims
-
1. A method for producing a neural cell population from human embryonic stem (hES) cells, comprising:
-
a) obtaining a population of hES cells;
b) optionally initiating differentiation of the hES cells into a heterogeneous population of precursor cells; and
thenc) culturing the cells in a medium containing one or more added TGF-β
Superfamily Antagonists so as to produce a population having one or more of the following features;
i) at least 50% of the cells express polysialylated NCAM ii) at least 50% of the cells express β
-tubulin III;
oriii) at least 10% of the cells express both microtubule-associated protein 2 (MAP-2) and tyrosine hydroxylase. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)
-
Specification